Safeguard Scientifics expecting income boost from Clarient deal - Minneapolis / St. Paul Business Journal:

tenamup.wordpress.com
Life sciences and technology investor Safeguard said the gain and an increasein shareholders’ equity will be recognizes in the current quarter ending June 30. A private placemen t with reduced Safeguard’s share in Clarient from about 50 percent to about47 percent. Safeguard Presidenf and CEO Peter J. Boni said the deal “not only strengthened our balance sheet andfinancial flexibility, but the valuew of Safeguard’s ongoing stake in Clarientg can now be more readily understood by the investmentr community.
” Safeguard said the market value of its remaininh holdings is about $123 million as of Clarient provides anatomic pathology and molecular testing servicesd to pathologists, oncologists and the pharmaceutical It’s based in Aliso Viejo,